Paragon Genomics expands portfolio of CleanPlex SARS-CoV-2-related NGS tests
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing
EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Join us Thursday, October 22, to explore the applications and benefits of ambient ionization for biomedical research and its future potential for pharma and food industries
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2
Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases
Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions
Join us on Monday, October 19, to find out how targeting BCMA and GPRC5D simultaneously could help to prevent tumor cell escape
Harvey J. Alter, Michael Houghton, and Charles M. Rice are joint winners of 2020 Nobel Prize for medicine
Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology
We speak with Dr. Ed Emmott, founder of The Emmott Lab & COVID-19 Mass Spec Coalition member, about his latest research into the disease
Affimer-based research assay launched alongside performance data published by Bruker